Floatz logo

Apsolol

Myocardial Disorder

Chang-Ik YoonSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Myocardial Disorder cohort.

Asset / SponsorPhaseRating
Atorvastatin
Cedars-Sinai Medical Center
Phase 2CCC
Ibuprofen
Haukeland University Hospital
UnknownD
Epinephrine
Haukeland University Hospital
UnknownD
Noradrenaline Tartrate Impurity C
Haukeland University Hospital
UnknownD
Dl-Dobutamine
University of Hamburg-Eppendorf
N/AD
Noradrenaline
Haukeland University Hospital
UnknownD

Same molecule, other indications

Apsolol is also rated in:

esophageal varicesActive
BBB
Indicative · Phase 4
74 / 100
View asset →
migraine disorderActive
BBB
Indicative · Phase 4
74 / 100
View asset →
esophageal varices with bleedingActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →